Clinical Management of COPD in the Real World: Can Studies Reveal Errors in Management and Pathways to Improve Patient Care?

References

• Agustí A, Celli BR, Criner GJ, et al. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. Am J Respir Crit Care Med. 2023;207(7):819–837. doi:10.1164/rccm.202301-0106PP
   PubMed Web of Science ®Google Scholar
• Jones RC, Price D, Ryan D, et al. Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort. Lancet Respir Med. 2014;2(4):267–276. doi:10.1016/S2213-2600(14)70008-6
   PubMed Web of Science ®Google Scholar
• Halpin DMG, de Jong HJI, Carter V, Skinner D, Price D. Distribution, Temporal Stability and Appropriateness of Therapy of Patients With COPD in the UK in Relation to GOLD 2019. eClinicalMedicine. 2019;14:32–41. doi:10.1016/j.eclinm.2019.07.003
   PubMedGoogle Scholar
• Sherman RE, Anderson SA, Dal Pan GJ, et al. Real-world evidence - what is it and what can it tell us? N Engl J Med. 2016;375(23):2293–2297. doi:10.1056/NEJMsb1609216
   PubMed Web of Science ®Google Scholar
• Roche N, Reddel HK, Agusti A, et al. Integrating real-life studies in the global therapeutic research framework. Lancet Respir Med. 2013;1(10):e29–30. doi:10.1016/S2213-2600(13)70199-1
   PubMed Web of Science ®Google Scholar
• Gershon AS, Lindenauer PK, Wilson KC, et al. Informing Healthcare Decisions with Observational Research Assessing Causal Effect. An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2021;203(1):14–23. doi:10.1164/rccm.202010-3943ST
   PubMed Web of Science ®Google Scholar
• Millares Martin P. Consultation analysis: use of free text versus coded text. Health Technol (Berl). 2021;11(2):349–357. doi:10.1007/s12553-020-00517-3
   PubMed Web of Science ®Google Scholar
• Tulloch JS, Beadsworth MB, Vivancos R, Radford AD, Warner JC, Christley RM. GP coding behaviour for non-specific clinical presentations: a pilot study. BJGP Open. 2020;4(3). doi:10.3399/bjgpopen20X101050
   PubMedGoogle Scholar
• Halpin DM, Kerkhof M, Soriano JB, Mikkelsen H, Price DB. Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy. Respir Res. 2016;17(1):120. doi:10.1186/s12931-016-0433-5
   PubMed Web of Science ®Google Scholar
• Vestbo J, Leather D, Diar Bakerly N, et al. Effectiveness of Fluticasone Furoate-Vilanterol for COPD in Clinical Practice. N Engl J Med. 2016;375(13):1253–1260. doi:10.1056/NEJMoa1608033
   PubMed Web of Science ®Google Scholar
• Halpin DMG, Worsley S, Ismaila AS, et al. INTREPID: single- versus multiple-inhaler triple therapy for COPD in usual clinical practice. ERJ Open Res. 2021;7(2). doi:10.1183/23120541.00950-2020
   Google Scholar
• Food and Drug Administration. Framework for FDA’s real-world evidence program; 2018. Available from: https://www.fda.gov/media/120060/download. Accessed July 27, 2023.
   Google Scholar
• Cave A, Kurz X, Arlett P. Real-World Data for Regulatory Decision Making: challenges and Possible Solutions for Europe. Clin Pharmacol Ther. 2019;106(1):36–39. doi:10.1002/cpt.1426
   PubMed Web of Science ®Google Scholar
• Arlett P, Kjaer J, Broich K, Cooke E. Real-World Evidence in EU Medicines Regulation: enabling Use and Establishing Value. Clin Pharmacol Ther. 2022;111(1):21–23. doi:10.1002/cpt.2479
   PubMed Web of Science ®Google Scholar
• Kostikas K, Price D, Gutzwiller FS, et al. Clinical Impact and Healthcare Resource Utilization Associated with Early versus Late COPD Diagnosis in Patients from UK CPRD Database. Int J Chron Obstruct Pulmon Dis. 2020;15:1729–1738. doi:10.2147/COPD.S255414
   PubMed Web of Science ®Google Scholar
• Halpin DMG, Dickens AP, Skinner D, et al. Identification of key opportunities for optimising the management of high-risk COPD patients in the UK using the CONQUEST Quality Standards: an observational longitudinal study. Lancet Reg Health Eur. 2023;29:100619. doi:10.1016/j.lanepe.2023.100619
   PubMedGoogle Scholar
• Fisk M, McMillan V, Brown J, et al. Inaccurate diagnosis of COPD: the Welsh National COPD Audit. Br J Gen Pract. 2019;69(678):e1–e7. doi:10.3399/bjgp18X700385
   PubMed Web of Science ®Google Scholar
• Koefoed MM, dePont Christensen R, Søndergaard J, Jarbøl DE. Lack of spirometry use in Danish patients initiating medication targeting obstructive lung disease. Respir Med. 2012;106(12):1743–1748. doi:10.1016/j.rmed.2012.09.012
   PubMed Web of Science ®Google Scholar
• Arne M, Lisspers K, Stallberg B, et al. How often is diagnosis of COPD confirmed with spirometry? Respir Med. 2010;104(4):550–556. doi:10.1016/j.rmed.2009.10.023
   PubMed Web of Science ®Google Scholar
• Kim KY, Yoo KH, Choi HS, et al. Nationwide quality assessment of treatment for chronic obstructive pulmonary disease. J Thorac Dis. 2020;12(12):7174–7181. doi:10.21037/jtd-20-905
   PubMed Web of Science ®Google Scholar
• Nishi SP, Wang Y, Kuo YF, Goodwin JS, Sharma G. Spirometry use among older adults with chronic obstructive pulmonary disease: 1999-2008. Ann Am Thorac Soc. 2013;10(6):565–573. doi:10.1513/AnnalsATS.201302-037OC
   PubMedGoogle Scholar
• Asthma + Lung UK. Delayed diagnosis and unequal care: the reality for people with chronic obstructive pulmonary disease (COPD) in the UK in 2022; 2022. Available from: https://www.asthmaandlung.org.uk/wp-content/uploads/2022/11/COPD-SURVEY-2022_5a.pdf. Accessed July 27, 2023.
   Google Scholar
• National COPD Audit Programme. Planning for every breath. National Chronic Obstructive Pulmonary Disease (COPD) Audit Programme. Primary Care Audit. 2017;1:67.
   Google Scholar
• National Institute for Health and Care Excellence (NICE). Chronic Obstructive Pulmonary Disease in Over 16s: Diagnosis and Management. NICE Guideline [NG115]. National Institute for Health and Care Excellence; 2022.
   Google Scholar
• O’Halloran L, Purcell A, Ryan E, et al. A snapshot of chronic obstructive pulmonary disease management in general practice in Ireland. Ir J Med Sci. 2021;190(3):1055–1061. doi:10.1007/s11845-020-02435-9
   PubMed Web of Science ®Google Scholar
• Liu Y, Greenlund KJ, VanFrank B, Xu F, Lu H, Croft JB. Smoking Cessation Among U.S. Adult Smokers With and Without Chronic Obstructive Pulmonary Disease, 2018. Am J Prev Med. 2022;62(4):492–502. doi:10.1016/j.amepre.2021.12.001
   PubMed Web of Science ®Google Scholar
• Pashutina Y, Kotz D, Kastaun S. Attempts to quit smoking, use of smoking cessation methods, and associated characteristics among COPD patients. NPJ Prim Care Respir Med. 2022;32(1):50. doi:10.1038/s41533-022-00316-5
   PubMed Web of Science ®Google Scholar
• Jimenez-Ruiz CA, Masa F, Miravitlles M, et al. Smoking characteristics: differences in attitudes and dependence between healthy smokers and smokers with COPD. CHEST. 2001;119(5):1365–1370. doi:10.1378/chest.119.5.1365
   PubMed Web of Science ®Google Scholar
• Crowley TJ, Macdonald MJ, Walter MI. Behavioral anti-smoking trial in chronic obstructive pulmonary disease patients. Psychopharmacology. 1995;119(2):193–204. doi:10.1007/BF02246161
   PubMed Web of Science ®Google Scholar
• van Eerd EAM, Bech Risor M, Spigt M, et al. Why do physicians lack engagement with smoking cessation treatment in their COPD patients? A multinational qualitative study. NPJ Prim Care Respir Med. 2017;27(1):41. doi:10.1038/s41533-017-0038-6
   PubMed Web of Science ®Google Scholar
• Buhl R, Wilke T, Picker N, et al. Real-World Treatment of Patients Newly Diagnosed with Chronic Obstructive Pulmonary Disease: a Retrospective German Claims Data Analysis. Int J Chron Obstruct Pulmon Dis. 2022;17:2355–2367. doi:10.2147/COPD.S375190
   PubMed Web of Science ®Google Scholar
• Bloom CI, Montonen J, Jöns O, Garry EM, Bhatt SP. First Maintenance Therapy for Chronic Obstructive Pulmonary Disease: retrospective Analyses of US and UK Healthcare Databases. Pulm Ther. 2022;8(1):57–74. doi:10.1007/s41030-021-00179-0
   PubMedGoogle Scholar
• Barrecheguren M, Monteagudo M, Ferrer J, et al. Treatment patterns in COPD patients newly diagnosed in primary care. A population-based study. Respir Med. 2016;111:47–53. doi:10.1016/j.rmed.2015.12.004
   PubMed Web of Science ®Google Scholar
• Bhatt SP, Blauer-Peterson C, Buysman EK, Bengtson LGS, Paine Iii SR. Trends and Characteristics of Global Initiative for Chronic Obstructive Lung Disease Guidelines-Discordant Prescribing of Triple Therapy Among Patients with COPD. Chronic Obstr Pulm Dis. 2022;9(2):135–153. doi:10.15326/jcopdf.2021.0256
   PubMed Web of Science ®Google Scholar
• Price D, West D, Brusselle G, et al. Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns. Int J Chron Obstruct Pulmon Dis. 2014;9:889–905. doi:10.2147/COPD.S62750
   PubMed Web of Science ®Google Scholar
• Corrado A, Rossi A. How far is real life from COPD therapy guidelines? An Italian Observational Study Respir Med. 2012;106(7):989–997.
   Google Scholar
• Palmiotti GA, Lacedonia D, Liotino V, et al. Adherence to GOLD guidelines in real-life COPD management in the Puglia region of Italy. Int J Chron Obstruct Pulmon Dis. 2018;13:2455–2462. doi:10.2147/COPD.S157779
   PubMed Web of Science ®Google Scholar
• Ding B, Small M, Holmgren U. A cross-sectional survey of current treatment and symptom burden of patients with COPD consulting for routine care according to GOLD 2014 classifications. Int J Chron Obstruct Pulmon Dis. 2017;12:1527–1537. doi:10.2147/COPD.S133793
   PubMed Web of Science ®Google Scholar
• Roche N, Lepage T, Bourcereau J, Terrioux P. Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease. Eur Respir J. 2001;18:903–908. doi:10.1183/09031936.01.00213701
   PubMed Web of Science ®Google Scholar
• Jochmann A, Scherr A, Jochmann DC, et al. Impact of adherence to the GOLD guidelines on symptom prevalence, lung function decline and exacerbation rate in the Swiss COPD cohort. Swiss Med Wkly. 2012;142:w13567. doi:10.4414/smw.2012.13567
   PubMed Web of Science ®Google Scholar
• Drivenes E, Ostrem A, Melbye H. Predictors of ICS/LABA prescribing in COPD patients: a study from general practice. BMC Fam Pract. 2014;15:42. doi:10.1186/1471-2296-15-42
   PubMed Web of Science ®Google Scholar
• Bourbeau J, Sebaldt RJ, Day A, et al. Practice patterns in the management of chronic obstructive pulmonary disease in primary practice: the CAGE study. Can Respir J. 2008;15(1):13–19. doi:10.1155/2008/173904
   PubMed Web of Science ®Google Scholar
• Roche N, Pribil C, Van Ganse E, et al. Real-life use of fluticasone propionate/salmeterol in patients with chronic obstructive pulmonary disease: a French observational study. BMC Pulm Med. 2014;14:56. doi:10.1186/1471-2466-14-56
   PubMed Web of Science ®Google Scholar
• Vestbo J, Vogelmeier CF, Small M, Siddall J, Fogel R, Kostikas K. Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population. Int J Chron Obstruct Pulmon Dis. 2019;14:853–861. doi:10.2147/COPD.S189585
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; 2023. Available from: http://www.goldcopd.org/. Accessed July 27, 2023.
   Google Scholar
• Mannino DM, Yu T-C, Zhou H, Higuchi K. Effects of GOLD-Adherent Prescribing on COPD Symptom Burden, Exacerbations, and Health Care Utilization in a Real-World Setting. Chronic Obstr Pulm Dis. 2015;2(3):223–235. doi:10.15326/jcopdf.2.3.2014.0151
   PubMedGoogle Scholar
• Palli SR, Zhou S, Shaikh A, Willey VJ. Effect of compliance with GOLD treatment recommendations on COPD health care resource utilization, cost, and exacerbations among patients with COPD on maintenance therapy. J Manag Care Spec Pharm. 2021;27(5):625–637. doi:10.18553/jmcp.2021.20390
   PubMed Web of Science ®Google Scholar
• Hurst JR, Dilleen M, Morris K, Hills S, Emir B, Jones R. Factors influencing treatment escalation from long-acting muscarinic antagonist monotherapy to triple therapy in patients with COPD: a retrospective THIN-database analysis. Int J Chron Obstruct Pulmon Dis. 2018;13:781–792. doi:10.2147/COPD.S153655
   PubMed Web of Science ®Google Scholar
• Mannino D, Bogart M, Germain G, et al. Benefit of Prompt versus Delayed Use of Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Following a COPD Exacerbation. Int J Chron Obstruct Pulmon Dis. 2022;17:491–504. doi:10.2147/COPD.S337668
   PubMed Web of Science ®Google Scholar
• Tkacz J, Evans KA, Touchette DR, et al. PRIMUS - Prompt Initiation of Maintenance Therapy in the US: a Real-World Analysis of Clinical and Economic Outcomes Among Patients Initiating Triple Therapy Following a COPD Exacerbation. Int J Chron Obstruct Pulmon Dis. 2022;17:329–342. doi:10.2147/COPD.S347735
   PubMed Web of Science ®Google Scholar
• Lutter JI, Lukas M, Schwarzkopf L, et al. Utilization and determinants of use of non-pharmacological interventions in COPD: results of the COSYCONET cohort. Respir Med. 2020;171:106087. doi:10.1016/j.rmed.2020.106087
   PubMed Web of Science ®Google Scholar
• Stone PW, Hickman K, Steiner MC, Roberts CM, Quint JK, Singh SJ. Predictors of Referral to Pulmonary Rehabilitation from UK Primary Care. Int J Chron Obstruct Pulmon Dis. 2020;15:2941–2952. doi:10.2147/COPD.S273336
   PubMed Web of Science ®Google Scholar
• Young-Xu Y, Smith J, Nealon J, et al. Influenza vaccine in chronic obstructive pulmonary disease among elderly male veterans. PLoS One. 2022;17(1):e0262072. doi:10.1371/journal.pone.0262072
   PubMed Web of Science ®Google Scholar
• Garrastazu R, Garcia-Rivero JL, Ruiz M, et al. Prevalence of Influenza Vaccination in Chronic Obstructive Pulmonary Disease Patients and Impact on the Risk of Severe Exacerbations. Arch Bronconeumol. 2016;52(2):88–95. doi:10.1016/j.arbres.2015.09.001
   PubMed Web of Science ®Google Scholar
• Ozlu T, Bulbul Y, Aydin D, et al. Immunization status in chronic obstructive pulmonary disease: a multicenter study from Turkey. Ann Thorac Med. 2019;14(1):75–82. doi:10.4103/atm.ATM_145_18
   PubMed Web of Science ®Google Scholar
• Gogou E, Hatzoglou C, Zarogiannis SG, et al. Are younger COPD patients adequately vaccinated for influenza and pneumococcus? Respir Med. 2022;203:106988. doi:10.1016/j.rmed.2022.106988
   PubMed Web of Science ®Google Scholar
• Lee H, Choi H, Jo YS. Trends in Influenza Vaccination Rates in Participants With Airflow Limitation: the Korea National Health and Nutrition Examination Survey 2007-2018. Front Med. 2022;9:870617. doi:10.3389/fmed.2022.870617
   Web of Science ®Google Scholar
• Cross AJ, Thomas D, Liang J, Abramson MJ, George J, Zairina E. Educational interventions for health professionals managing chronic obstructive pulmonary disease in primary care. Cochrane Database Syst Rev. 2022;5(5):CD012652. doi:10.1002/14651858.CD012652.pub2
   PubMedGoogle Scholar
• Henoch I, Strang S, Lofdahl CG, Ekberg-Jansson A. Management of COPD, equal treatment across age, gender, and social situation? A register study. Int J Chron Obstruct Pulmon Dis. 2016;11:2681–2690. doi:10.2147/COPD.S115238
   PubMed Web of Science ®Google Scholar
• Schrijver J, Lenferink A, Brusse-Keizer M, et al. Self-management interventions for people with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2022;1(1):CD002990. doi:10.1002/14651858.CD002990.pub4
   PubMed Web of Science ®Google Scholar
• Collier DJ, Wielders P, van der Palen J, et al. Critical Error Frequency and the Impact of Training with Inhalers Commonly used for Maintenance Treatment in Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2020;15:1301–1313. doi:10.2147/COPD.S224209
   PubMed Web of Science ®Google Scholar
• Hanania NA, Braman S, Adams SG, et al. The Role of Inhalation Delivery Devices in COPD: perspectives of Patients and Health Care Providers. Chronic Obstr Pulm Dis. 2018;5(2):111–123. doi:10.15326/jcopdf.5.2.2017.0168
   PubMed Web of Science ®Google Scholar
• Amin AN, Ganapathy V, Roughley A, Small M. Confidence in correct inhaler technique and its association with treatment adherence and health status among US patients with chronic obstructive pulmonary disease. Patient Prefer Adherence. 2017;11:1205–1212. doi:10.2147/PPA.S140139
   PubMed Web of Science ®Google Scholar
• Price D, Keininger DL, Viswanad B, Gasser M, Walda S, Gutzwiller FS. Factors associated with appropriate inhaler use in patients with COPD - lessons from the REAL survey. Int J Chron Obstruct Pulmon Dis. 2018;13:695–702. doi:10.2147/COPD.S149404
   PubMed Web of Science ®Google Scholar
• Kocks JWH, Wouters H, Bosnic-Anticevich S, et al. Factors associated with health status and exacerbations in COPD maintenance therapy with dry powder inhalers. NPJ Prim Care Respir Med. 2022;32(1):18. doi:10.1038/s41533-022-00282-y
   PubMed Web of Science ®Google Scholar
• National Asthma and Chronic Obstructive Pulmonary Disease Audit Programme (NACAP). COPD clinical audit 2019/20 (people with COPD exacerbations discharged from acute hospitals in England and Wales between October 2019 and February 2020); 2019. Available from: https://www.nacap.org.uk. Accessed July 27, 2023.
   Google Scholar
• The Royal College of Physicians of London, British Thoracic Society, British Lung Foundation. Report 5 of The National Chronic Obstructive Pulmonary Disease Audit 2008: survey of COPD care within UK General Practices 2008. Available from: http://www.rcplondon.ac.uk/file/1040/download. Accessed July 27, 2023.
   Google Scholar
• Lopez-Campos JL, Hartl S, Pozo-Rodriguez F, Roberts CM. Antibiotic Prescription for COPD Exacerbations Admitted to Hospital. European COPD Audit PLoS ONE. 2015;10(4):e0124374. doi:10.1371/journal.pone.0124374
   PubMed Web of Science ®Google Scholar
• Shah T, Churpek MM, Coca Perraillon M, Konetzka RT. Understanding why patients with COPD get readmitted: a large national study to delineate the Medicare population for the readmissions penalty expansion. CHEST. 2015;147(5):1219–1226. doi:10.1378/chest.14-2181
   PubMed Web of Science ®Google Scholar
• Royal College of Physicians National Asthma and Chronic Obstructive Pulmonary Disease Audit Programme (NACAP). Outcomes of patients included in the asthma and COPD clinical audit 2018/19 and/or 2019/20 clinical audit reports Audit Report London RCP; 2023. Available from. http://www.rcp.ac.uk/projects/outputs/clinical-outcomes-summary-report-201820. Accessed July 27, 2023.
   Google Scholar
• Baker CL, Zou KH, Su J. Risk assessment of readmissions following an initial COPD-related hospitalization. Int J Chron Obstruct Pulmon Dis. 2013;8:551–559. doi:10.2147/COPD.S51507
   PubMed Web of Science ®Google Scholar
• Yu TC, Zhou H, Suh K, Arcona S. Assessing the importance of predictors in unplanned hospital readmissions for chronic obstructive pulmonary disease. Clinicoecon Outcomes Res. 2015;7:37–51. doi:10.2147/CEOR.S74181
   PubMed Web of Science ®Google Scholar
• Milne RJ, Beasley R. Hospital admissions for chronic obstructive pulmonary disease in New Zealand. N Z Med J. 2015;128(1408):23–35.
   PubMed Web of Science ®Google Scholar
• Sharif R, Parekh TM, Pierson KS, Kuo YF, Sharma G. Predictors of early readmission among patients 40 to 64 years of age hospitalized for chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2014;11(5):685–694. doi:10.1513/AnnalsATS.201310-358OC
   PubMedGoogle Scholar
• Harries TH, Thornton H, Crichton S, Schofield P, Gilkes A, White PT. Hospital readmissions for COPD: a retrospective longitudinal study. NPJ Prim Care Respir Med. 2017;27(1):31. doi:10.1038/s41533-017-0028-8
   PubMed Web of Science ®Google Scholar
• Wilkinson T, North M, Bourne SC. Reducing hospital admissions and improving the diagnosis of COPD in Southampton City: methods and results of a 12-month service improvement project. NPJ Prim Care Respir Med. 2014;24:14035. doi:10.1038/npjpcrm.2014.35
   PubMed Web of Science ®Google Scholar
• Morrison RS, Meier DE. Clinical practice. Palliative Care N Engl J Med. 2004;350(25):2582–2590.
   Google Scholar
• Seamark DA, Seamark CJ, Halpin DM. Palliative care in chronic obstructive pulmonary disease: a review for clinicians. J R Soc Med. 2007;100(5):225–233. doi:10.1177/014107680710000512
   PubMed Web of Science ®Google Scholar
• Bloom CI, Slaich B, Morales DR, Smeeth L, Stone P, Quint JK. Low uptake of palliative care for COPD patients within primary care in the UK. Eur Resp J. 2018;51:1701879. doi:10.1183/13993003.01879-2017
   PubMed Web of Science ®Google Scholar
• Gershon AS, Maclagan LC, Luo J, et al. End-of-Life Strategies among Patients with Advanced Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2018;198(11):1389–1396. doi:10.1164/rccm.201803-0592OC
   PubMed Web of Science ®Google Scholar
• Gore JM, Brophy CJ, Greenstone MA. How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax. 2000;55(12):1000–1006. doi:10.1136/thorax.55.12.1000
   PubMed Web of Science ®Google Scholar
• Halpin DMG. Palliative care for people with COPD: effective but underused. Eur Respir J. 2018;51(2):1702645. doi:10.1183/13993003.02645-2017
   PubMed Web of Science ®Google Scholar
• Safiri S, Carson-Chahhoud K, Noori M, et al. Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019. BMJ. 2022;378:e069679. doi:10.1136/bmj-2021-069679
   PubMedGoogle Scholar
• GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–1222. doi:10.1016/S0140-6736(20)30925-9
   PubMed Web of Science ®Google Scholar
• Morganroth M, Pape G, Rozenfeld Y, Heffner JE. Multidisciplinary COPD disease management program: impact on clinical outcomes. Postgrad Med. 2016;128(2):239–249. doi:10.1080/00325481.2016.1129259
   PubMed Web of Science ®Google Scholar
• Terasaki J, Singh G, Zhang W, Wagner P, Sharma G. Using EMR to improve compliance with clinical practice guidelines for management of stable COPD. Respir Med. 2015;109(11):1423–1429. doi:10.1016/j.rmed.2015.10.003
   PubMed Web of Science ®Google Scholar
• Burkes RM, Mkorombindo T, Chaddha U, et al. Impact of Quality Improvement on Care of Chronic Obstructive Pulmonary Disease Patients in an Internal Medicine Resident Clinic. Healthcare. 2018;6(3):68.
   Web of Science ®Google Scholar
• Ferrone M, Masciantonio MG, Malus N, et al. The impact of integrated disease management in high-risk COPD patients in primary care. NPJ Prim Care Respir Med. 2019;29(1):8. doi:10.1038/s41533-019-0119-9
   PubMed Web of Science ®Google Scholar
• Cosío BG, Shafiek H, Verdú J, et al. Implementation of an Integrated Care Model for Frequent-Exacerbator COPD Patients: a Controlled Prospective Study. Arch Bronconeumol. 2021;57(9):577–583. doi:10.1016/j.arbres.2021.01.025
   PubMed Web of Science ®Google Scholar
• Poot CC, Meijer E, Kruis AL, Smidt N, Chavannes NH, Honkoop PJ. Integrated disease management interventions for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2021;9(9):CD009437. doi:10.1002/14651858.CD009437.pub3
   PubMedGoogle Scholar
• Wu CX, Hwang CH, Tan WS, et al. Effectiveness of a chronic obstructive pulmonary disease integrated care pathway in a regional health system: a propensity score matched cohort study. BMJ Open. 2018;8(3):e019425. doi:10.1136/bmjopen-2017-019425
   PubMed Web of Science ®Google Scholar
• Lanning E, Longstaff J, Jones T, et al. Modern Innovative Solutions in Improving Outcomes in Chronic Obstructive Pulmonary Disease (MISSION COPD): mixed Methods Evaluation of a Novel Integrated Care Clinic. Interact J Med Res. 2019;8(4):e9637. doi:10.2196/ijmr.9637
   PubMed Web of Science ®Google Scholar
• Kruis AL, Boland MR, Assendelft WJ, et al. Effectiveness of integrated disease management for primary care chronic obstructive pulmonary disease patients: results of cluster randomised trial. BMJ. 2014;349:g5392. doi:10.1136/bmj.g5392
   PubMed Web of Science ®Google Scholar
• Trout D, Bhansali AH, Riley DD, Peyerl FW, Lee-Chiong TL Jr. A quality improvement initiative for COPD patients: a cost analysis. PLoS One. 2020;15(7):e0235040.
   PubMed Web of Science ®Google Scholar
• Pullen R, Miravitlles M, Sharma A, et al. CONQUEST Quality Standards: for the Collaboration on Quality Improvement Initiative for Achieving Excellence in Standards of COPD Care. Int J Chron Obstruct Pulmon Dis. 2021;16:2301–2322. doi:10.2147/COPD.S313498
   PubMed Web of Science ®Google Scholar
• Alves L, Pullen R, Hurst JR, et al. CONQUEST: a Quality Improvement Program for Defining and Optimizing Standards of Care for Modifiable High-Risk COPD Patients. Relat Outcome Meas. 2022;13:53–68.
   Web of Science ®Google Scholar